{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:20:32Z","timestamp":1778055632060,"version":"3.51.4"},"reference-count":108,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Provincial Health Commission","award":["23LCYJ041"],"award-info":[{"award-number":["23LCYJ041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Venous thromboembolism (VTE) is a clinically significant complication in patients with breast cancer (BC) and may disrupt treatment continuity while contributing to adverse outcomes. Although BC is generally regarded as a relatively low-risk malignancy for VTE compared with several other cancer types, its high incidence and the increasing use of multimodal therapies have resulted in a growing clinical burden of breast cancer-associated VTE. This review summarizes the epidemiological features, risk factors, biological mechanisms, and advances in the prevention and management of breast cancer-associated VTE. Current evidence indicates that patients with cancer have an approximately 4- to 7-fold higher risk of VTE than the general population, with the risk in BC being particularly pronounced during the first 3\u20136 months after diagnosis. Older age, metabolic comorbidities, advanced disease, and exposure to multiple anticancer therapies have all been associated with an increased risk of VTE. Mechanistically, tissue factor, procoagulant extracellular vesicles, neutrophil extracellular traps, and inflammatory signaling pathways may contribute to breast cancer-associated VTE by promoting coagulation activation and endothelial dysfunction, while also linking thrombosis to immune evasion and Smetastatic progression. Improved identification of high-risk patients, optimization of dynamic risk assessment, and the implementation of individualized prophylactic and anticoagulant strategies may help improve outcomes in patients with BC.<\/jats:p>","DOI":"10.3390\/cancers18091486","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:36:23Z","timestamp":1778052983000},"page":"1486","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer-Associated Venous Thromboembolism: Risk Factors, Mechanisms, and Clinical Management"],"prefix":"10.3390","volume":"18","author":[{"given":"Panlin","family":"Xie","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunbo","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingmi","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global Patterns and Trends in Breast Cancer Incidence and Mortality across 185 Countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"2019 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Guidance from the SSC of the ISTH","volume":"16","author":"Khorana","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of Venous Thrombosis in a Large Cohort of 66 329 Cancer Patients: Results of a Record Linkage Study","volume":"4","author":"Blom","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous Thromboembolism in Cancer Patients: A Population-Based Cohort Study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2015-01-625582","article-title":"When Are Breast Cancer Patients at Highest Risk of Venous Thromboembolism? A Cohort Study Using English Health Care Data","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12282-023-01452-7","article-title":"Venous Thromboembolism in Japanese Patients with Breast Cancer: Subgroup Analysis of the Cancer-VTE Registry","volume":"30","author":"Ohsumi","year":"2023","journal-title":"Breast Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Londero, A.P., Bertozzi, S., Cedolini, C., Neri, S., Bulfoni, M., Orsaria, M., Mariuzzi, L., Uzzau, A., Risaliti, A., and Barillari, G. (2022). Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery. Cancers, 14.","DOI":"10.3390\/cancers14040988"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Khan, U.T., Walker, A.J., Baig, S., Card, T.R., Kirwan, C.C., and Grainge, M.J. (2017). Venous Thromboembolism and Mortality in Breast Cancer: Cohort Study with Systematic Review and Meta-Analysis. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3719-1"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.12778","article-title":"Factor V Leiden Mutation Increases the Risk for Venous Thromboembolism in Cancer Patients\u2014Results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"13","author":"Pabinger","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ajh.27222","article-title":"Inherited Thrombophilia Gene Mutations and Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis","volume":"99","author":"Roy","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia Testing: A British Society for Haematology Guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.jtha.2023.07.009","article-title":"Polygenic Risk Scores for Prediction of Cancer-Associated Venous Thromboembolism in the UK Biobank Cohort Study","volume":"21","author":"Guman","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/annonc\/mdq777","article-title":"Risk Factors and Incidence of Thromboembolic Events (TEEs) in Older Men and Women with Breast Cancer","volume":"22","author":"Zhao","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2006.07.4393","article-title":"Incidence of Venous Thromboembolism and the Impact on Survival in Breast Cancer Patients","volume":"25","author":"Chew","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, Risk Factors, and Trends for Venous Thromboembolism among Hospitalized Cancer Patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e005082","DOI":"10.1136\/bmjopen-2014-005082","article-title":"Impact of Comorbidity on Risk of Venous Thromboembolism in Patients with Breast Cancer: A Danish Population-Based Cohort Study","volume":"4","author":"Ording","year":"2014","journal-title":"BMJ Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.30364","article-title":"Time-dependent Risk and Predictors of Venous Thromboembolism in Breast Cancer Patients: A Population-based Cohort Study","volume":"123","author":"Brand","year":"2017","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.7150\/thno.53637","article-title":"Phosphatidylserine-Exposing Tumor-Derived Microparticles Exacerbate Coagulation and Cancer Cell Transendothelial Migration in Triple-Negative Breast Cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jtha.2024.01.003","article-title":"The Breast Cancer Coagulome in the Tumor Microenvironment and Its Role in Prognosis and Treatment Response to Chemotherapy","volume":"22","author":"Tinholt","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.sla.0000193832.40178.0a","article-title":"Incidence and Prevention of Venous Thromboembolism in Patients Undergoing Breast Cancer Surgery and Treated According to Clinical Pathways","volume":"243","author":"Andtbacka","year":"2006","journal-title":"Ann. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1158\/1078-0432.CCR-16-1110","article-title":"Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients","volume":"22","author":"Brand","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jjco\/hyae055","article-title":"Incidence and Risk Factors of PICC-Related Thrombosis in Breast Cancer: A Meta-Analysis","volume":"54","author":"Meng","year":"2024","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/cncr.24508","article-title":"Tamoxifen Treatment and Risk of Deep Venous Thrombosis and Pulmonary Embolism: A Danish Population-Based Cohort Study","volume":"115","author":"Hernandez","year":"2009","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10549-018-05086-8","article-title":"Aromatase Inhibitor and Tamoxifen Use and the Risk of Venous Thromboembolism in Breast Cancer Survivors","volume":"174","author":"Xu","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1182\/bloodadvances.2021006623","article-title":"Differential Impact of Tamoxifen and Aromatase Inhibitors on Thrombin Generation: The Prospective HEMOBREAST Cohort","volume":"6","author":"Blondon","year":"2022","journal-title":"Blood Adv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jtha.2022.12.001","article-title":"Cyclin-Dependent Kinase 4\/6 Inhibitor-Associated Thromboembolism: A Critical Evaluation of the Current Evidence","volume":"21","author":"Watson","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.thromres.2021.11.009","article-title":"Risk of Venous and Arterial Thromboembolic Events in Women with Advanced Breast Cancer Treated with CDK 4\/6 Inhibitors: A Systematic Review and Meta-Analysis","volume":"208","author":"Bolzacchini","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.thromres.2021.12.025","article-title":"Contemporary Breast Cancer Treatment-Associated Thrombosis","volume":"213","author":"Kirwan","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102985","DOI":"10.1016\/j.rpth.2025.102985","article-title":"Radiotherapy-the Not-so-Insignificant Contributor to Cancer-Associated Venous Thrombosis","volume":"9","author":"Gurumurthy","year":"2025","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Park, J.H., Ahn, S.E., Kwon, L.M., Ko, H.H., Kim, S., Suh, Y.J., Kim, H.Y., Park, K.-H., and Kim, D. (2023). The Risk of Venous Thromboembolism in Korean Patients with Breast Cancer: A Single-Center Experience. Cancers, 15.","DOI":"10.3390\/cancers15123124"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2017.09.015","article-title":"What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients\u2019 Quality of Life?","volume":"21","author":"Lloyd","year":"2018","journal-title":"Value Health J. Int. Soc. Pharmacoecon. Outcomes Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamainternmed.2013.563","article-title":"Estimating Quality of Life in Acute Venous Thrombosis","volume":"173","author":"Hogg","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer","volume":"164","author":"Lyman","year":"2018","journal-title":"Thromb. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CEOR.S39964","article-title":"Health Care Costs Associated with Venous Thromboembolism in Selected High-Risk Ambulatory Patients with Solid Tumors Undergoing Chemotherapy in the United States","volume":"5","author":"Khorana","year":"2013","journal-title":"Clin. Outcomes Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1054\/bjoc.2000.1272","article-title":"Tissue Factor Expression in Breast Cancer Tissues: Its Correlation with Prognosis and Plasma Concentration","volume":"83","author":"Ueno","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.thromres.2017.09.019","article-title":"Breast-Cancer Extracellular Vesicles Induce Platelet Activation and Aggregation by Tissue Factor-Independent and -Dependent Mechanisms","volume":"159","author":"Gomes","year":"2017","journal-title":"Thromb. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2007.02369.x","article-title":"Microparticle-Associated Tissue Factor Activity: A Link between Cancer and Thrombosis?","volume":"5","author":"Tesselaar","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Che, S.P.Y., Park, J.Y., and Stokol, T. (2017). Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor-1. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00261"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI110203","article-title":"A Factor X-Activating Cysteine Protease from Malignant Tissue","volume":"67","author":"Gordon","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e38831","DOI":"10.1016\/j.heliyon.2024.e38831","article-title":"Blood Hypercoagulability and Thrombosis Mechanisms in Cancer Patients -a Brief Review","volume":"10","author":"Peng","year":"2024","journal-title":"Heliyon"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.cell.2025.01.025","article-title":"Extracellular Vesicles from the Lung Pro-Thrombotic Niche Drive Cancer-Associated Thrombosis and Metastasis via Integrin Beta 2","volume":"188","author":"Lucotti","year":"2025","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"59086","DOI":"10.18632\/oncotarget.19175","article-title":"Pathological Expression of Tissue Factor Confers Promising Antitumor Response to a Novel Therapeutic Antibody SC1 in Triple Negative Breast Cancer and Pancreatic Adenocarcinoma","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"216221","DOI":"10.1016\/j.canlet.2023.216221","article-title":"Tissue Factor Overexpression in Triple-Negative Breast Cancer Promotes Immune Evasion by Impeding T-Cell Infiltration and Effector Function","volume":"565","author":"Ren","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_47","first-page":"e155","article-title":"Release of Prometastatic Platelet-Derived Microparticles Induced by Breast Cancer Cells: A Novel Positive Feedback Mechanism for Metastasis","volume":"1","author":"Guidetti","year":"2017","journal-title":"TH Open Companion J. Thromb. Haemost."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardiores.2005.04.007","article-title":"Platelet-Derived Microparticles Induce Angiogenesis and Stimulate Post-Ischemic Revascularization","volume":"67","author":"Brill","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2021.01.008","article-title":"Blocking Podoplanin Inhibits Platelet Activation and Decreases Cancer-Associated Venous Thrombosis","volume":"200","author":"Wang","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jtha.2023.07.005","article-title":"Cancer-Associated Fibroblasts Promote Venous Thrombosis through Podoplanin\/CLEC-2 Interaction in Podoplanin-Negative Lung Cancer Mouse Model","volume":"21","author":"Shirai","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15881","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA Traps Promote Thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers Predispose Neutrophils to Release Extracellular DNA Traps That Contribute to Cancer-Associated Thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/jth.15794","article-title":"Breast Cancer Cells Mediate Endothelial Cell Activation, Promoting von Willebrand Factor Release, Tumor Adhesion, and Transendothelial Migration","volume":"20","author":"Dhami","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1007\/s10753-022-01711-3","article-title":"Interleukin-6 Downregulates the Expression of Vascular Endothelial-Cadherin and Increases Permeability in Renal Glomerular Endothelial Cells via the Trans-Signaling Pathway","volume":"45","author":"Yang","year":"2022","journal-title":"Inflammation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"966","DOI":"10.7150\/ijbs.6996","article-title":"Interleukin-8 Regulates Endothelial Permeability by down-Regulation of Tight Junction but Not Dependent on Integrins Induced Focal Adhesions","volume":"9","author":"Yu","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium--Role in Regulation of Coagulation and Inflammation","volume":"34","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between Interleukin-6 Signaling and the Vascular Endothelium in Cytokine Storms","volume":"53","author":"Kang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1158\/1541-7786.MCR-09-0015","article-title":"CXCR4 and Matrix Metalloproteinase-1 Are Elevated in Breast Carcinoma-Associated Fibroblasts and in Normal Mammary Fibroblasts Exposed to Factors Secreted by Breast Cancer Cells","volume":"7","author":"Eck","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Osuala, K.O., Sameni, M., Shah, S., Aggarwal, N., Simonait, M.L., Franco, O.E., Hong, Y., Hayward, S.W., Behbod, F., and Mattingly, R.R. (2015). Il-6 Signaling between Ductal Carcinoma in Situ Cells and Carcinoma-Associated Fibroblasts Mediates Tumor Cell Growth and Migration. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1576-3"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0042-1758791","article-title":"Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)","volume":"49","author":"Morrow","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","article-title":"Therapeutics Targeting the Fibrinolytic System","volume":"52","author":"Lin","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients","volume":"94","author":"Look","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.bjc.6600662","article-title":"Independent Prognostic Value of Angiogenesis and the Level of Plasminogen Activator Inhibitor Type 1 in Breast Cancer Patients","volume":"88","author":"Hansen","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Fortenberry, Y.M., Brandal, S.M., Carpentier, G., Hemani, M., and Pathak, A.P. (2016). Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164288"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, Obesity, and Thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kwaifa, I.K., Bahari, H., Yong, Y.K., and Noor, S.M. (2020). Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules, 10.","DOI":"10.3390\/biom10020291"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Sobczak, A.I.S., and Stewart, A.J. (2019). Coagulatory Defects in Type-1 and Type-2 Diabetes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246345"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2010.03910.x","article-title":"Hyperglycemia: A Prothrombotic Factor?","volume":"8","author":"Lemkes","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Batten, L., Sathyapalan, T., and Palmer, T.M. (2023). Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417465"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCRESAHA.118.312563","article-title":"Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease","volume":"123","author":"Donato","year":"2018","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2016.09.019","article-title":"Endothelial Cell Senescence and Thrombosis: Ageing Clots","volume":"147","author":"Bochenek","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1111\/jth.15487","article-title":"Venous Thromboembolism Associated with Central Venous Catheters in Patients with Cancer: From Pathophysiology to Thromboprophylaxis, Areas for Future Studies","volume":"19","author":"Debourdeau","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","article-title":"Cancer Therapy-Associated Thrombosis","volume":"41","author":"Grover","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/bjc.2017.214","article-title":"Platelet Releasate Promotes Breast Cancer Growth and Angiogenesis via VEGF-Integrin Cooperative Signalling","volume":"117","author":"Jiang","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"107704","DOI":"10.1016\/j.isci.2023.107704","article-title":"Activated Platelets Facilitate Hematogenous Metastasis of Breast Cancer by Modulating the PDGFR-\u03b2\/COX-2 Axis","volume":"26","author":"Tang","year":"2023","journal-title":"iScience"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1038\/s41467-024-47516-w","article-title":"Platelets Favor the Outgrowth of Established Metastases","volume":"15","author":"Liboni","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood.2023022928","article-title":"Procoagulant Platelets Promote Immune Evasion in Triple-Negative Breast Cancer","volume":"144","author":"Schaubaecher","year":"2024","journal-title":"Blood"},{"key":"ref_78","first-page":"1146","article-title":"Platelet Glycoprotein VI Promotes Metastasis through Interaction with Cancer Cell-Derived Galectin-3","volume":"135","author":"Sarukhanyan","year":"2020","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1182\/blood-2010-06-289314","article-title":"Cooperation of Tissue Factor Cytoplasmic Domain and PAR2 Signaling in Breast Cancer Development","volume":"116","author":"Schaffner","year":"2010","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-05-1735","article-title":"Protease-Activated Receptor-2 Is Essential for Factor VIIa and Xa-Induced Signaling, Migration, and Invasion of Breast Cancer Cells","volume":"66","author":"Morris","year":"2006","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1038\/onc.2008.84","article-title":"Persistent Transactivation of EGFR and ErbB2\/HER2 by Protease-Activated Receptor-1 Promotes Breast Carcinoma Cell Invasion","volume":"27","author":"Arora","year":"2008","journal-title":"Oncogene"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","article-title":"Fibrinogen Is an Important Determinant of the Metastatic Potential of Circulating Tumor Cells","volume":"96","author":"Palumbo","year":"2000","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1158\/0008-5472.CAN-04-2078","article-title":"Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation","volume":"64","author":"Im","year":"2004","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e2202984","DOI":"10.1002\/adhm.202202984","article-title":"Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks","volume":"12","author":"Angelidakis","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","article-title":"Neutrophil Extracellular Traps Promote Pre-Metastatic Niche Formation in the Omentum by Expanding Innate-like B Cells That Express IL-10","volume":"43","author":"Lee","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C Promotes Breast Cancer Lung Metastasis by Modulating Neutrophil Infiltration and Neutrophil Extracellular Trap Formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Guideline Update","volume":"41","author":"Key","year":"2023","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana Score for Prediction of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","article-title":"Validation of the Khorana Score for Predicting Venous Thromboembolism in 40 218 Patients with Cancer Initiating Chemotherapy","volume":"6","author":"Overvad","year":"2022","journal-title":"Blood Adv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e1083","DOI":"10.1634\/theoncologist.2019-0482","article-title":"External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model","volume":"25","author":"Spyropoulos","year":"2020","journal-title":"Oncologist"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.mayocp.2020.06.015","article-title":"Perioperative Venous Thromboembolism Prophylaxis","volume":"95","author":"Bartlett","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bjh.18737","article-title":"Machine Learning to Predict Major Bleeding during Anticoagulation for Venous Thromboembolism: Possibilities and Limitations","volume":"201","author":"Mora","year":"2023","journal-title":"Br. J. Haematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-Associated Pathways and Biomarkers of Venous Thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/ajh.27379","article-title":"The Prognostic Value of Blood Cellular Indices in Pulmonary Embolism","volume":"99","author":"Siddiqui","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jamcollsurg.2019.11.010","article-title":"Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation","volume":"230","author":"Kim","year":"2020","journal-title":"J. Am. Coll. Surg."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/jth.12527","article-title":"Catheter-Associated Deep Vein Thrombosis of the Upper Extremity in Cancer Patients: Guidance from the SSC of the ISTH","volume":"12","author":"Zwicker","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s Choice\u2014European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Writing Committee Members, Creager, M.A., Barnes, G.D., Giri, J., Mukherjee, D., Jones, W.S., Burnett, A.E., Carman, T., Casanegra, A.I., and Castellucci, L.A. (2026). 2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 153, e977\u2013e1051.","DOI":"10.1161\/CIR.0000000000001415"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-022-01289-1","article-title":"Direct Oral Anticoagulant versus Low Molecular Weight Heparin for the Treatment of Cancer-Associated Venous Thromboembolism: 2022 Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"15","author":"Frere","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-0040-1720975","article-title":"Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study","volume":"121","author":"Ageno","year":"2021","journal-title":"Thromb. Haemost."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.14774","article-title":"Dynamic Assessment of Venous Thromboembolism Risk in Patients with Cancer by Longitudinal D-Dimer Analysis: A Prospective Study","volume":"18","author":"Posch","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_105","first-page":"33","article-title":"Mechanisms and Biomarkers of Cancer-Associated Thrombosis","volume":"225","author":"Kim","year":"2020","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jtha.2024.11.001","article-title":"Machine Learning Models for Risk Prediction of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis","volume":"23","author":"Chen","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.2023020722","article-title":"Targeting Factor XI and Factor XIa to Prevent Thrombosis","volume":"143","author":"Gailani","year":"2024","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/jth.15753","article-title":"Statin Use and 30-Day Mortality in Patients with Acute Symptomatic Pulmonary Embolism","volume":"20","author":"Siniscalchi","year":"2022","journal-title":"J. Thromb. Haemost."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1486\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:58:49Z","timestamp":1778054329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":108,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18091486"],"URL":"https:\/\/doi.org\/10.3390\/cancers18091486","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}